← back to search

Arman Jahangiri

University of Miami · US
Area of research
Genetics · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Glioma Diagnosis and Treatment, Pituitary Gland Disorders and Treatments, Cancer, Hypoxia, and Metabolism, and Cell Adhesion Molecules Research.
h-index
32
citations
5,002
works
193
NIH funding
primary concept
email

Recent publications

Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications
Journal of Neuro-Oncology 2025cited by 8position: middledoi
Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
JAMA Oncology 2020cited by 633position: middledoi
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance
Cancer Research 2020cited by 60position: middledoi
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment
Cancer Cell 2018cited by 262position: middledoi
Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy
Oncogene 2017cited by 141position: middledoi
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
Proceedings of the National Academy of Sciences 2017cited by 81position: firstdoi
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance
JCI Insight 2017cited by 64position: middledoi
Postoperative Delirium in Glioblastoma Patients
Neurosurgery 2017cited by 44position: middledoi
ANGI-07. OXIDIZED MIF DRIVES GLIOBLASTOMA CELL INVASION DURING BEVACIZUMAB RESISTANCE THROUGH UNIQUE SIGNALING MECHANISMS
Neuro-Oncology 2017cited by 1position: middledoi
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
The Lancet Oncology 2016cited by 368position: middledoi
HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth
Cell Reports 2015cited by 104position: middledoi
Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis
Journal of neurosurgery 2015cited by 102position: firstdoi
Factors Predicting Recurrence After Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities
Neurosurgery 2015cited by 82position: firstdoi
Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery
Journal of Clinical Neuroscience 2014cited by 170position: middledoi
Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations
Journal of neurosurgery 2014cited by 76position: firstdoi
Deep Arteriovenous Malformations in the Basal Ganglia, Thalamus, and Insula: Multimodality Management, Patient Selection, and Results
World Neurosurgery 2014cited by 51position: middledoi
β1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
Cancer Research 2013cited by 158position: middledoi
Rathke’s cleft cysts: review of natural history and surgical outcomes
Journal of Neuro-Oncology 2013cited by 138position: middledoi
Endoscopic surgery for tuberculum sellae meningiomas: a systematic review and meta-analysis
Neurosurgical Review 2013cited by 102position: middledoi
A Comprehensive Long-term Retrospective Analysis of Silent Corticotrophic Adenomas vs Hormone-Negative Adenomas
Neurosurgery 2013cited by 92position: firstdoi
Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations
Journal of neurosurgery 2013cited by 91position: firstdoi
Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
Cancer Research 2012cited by 475position: middledoi
Tumor Cell Autophagy as an Adaptive Response Mediating Resistance to Treatments Such as Antiangiogenic Therapy
Cancer Research 2012cited by 199position: middledoi
Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy
Clinical Cancer Research 2012cited by 114position: middledoi
Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy
Autophagy 2012cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Manish K. Aghi · Pediatric Brain Tumor Foundation20 papers (2012–2020)Patrick M. Flanigan · Mayo Clinic5 papers (2017–2017)Michael W. McDermott · University of California, San Francisco5 papers (2013–2017)Sandeep Kunwar · University of California, San Francisco5 papers (2013–2015)Michael De Lay · Neurological Surgery4 papers (2012–2017)Ankush Chandra · The University of Texas Health Science Center4 papers (2017–2020)Alan Nguyen · Neurological Surgery4 papers (2017–2020)Yulong Hu · Nanchang University4 papers (2012–2012)Jeffrey R. Wagner · University of Colorado Anschutz Medical Campus4 papers (2013–2017)Lewis S. Blevins · University of California, San Francisco4 papers (2013–2015)Michael DeLay · IDEXX Laboratories (United States)4 papers (2012–2013)Garima Yagnik · University of California, San Francisco4 papers (2017–2020)Maxwell W. Tom · Neurological Surgery4 papers (2012–2015)William Chen · Victoria University3 papers (2017–2020)Smita Mascharak · Brooklyn College3 papers (2017–2017)Jeffrey Wagner · University of Colorado Anschutz Medical Campus3 papers (2013–2014)Mai T. Tran · Australian Regenerative Medicine Institute3 papers (2013–2015)Ivan H. El‐Sayed · Kafrelsheikh University3 papers (2013–2015)W. Shawn Carbonell · Ansys (United States)3 papers (2012–2013)Sung Won Han · University of Seoul3 papers (2014–2017)